单次与分期多支血管PCI策略的临床结局比较
本研究基于日本京都PCI/CABG注册队列-2,纳入2018例择期多支血管PCI患者,比较单次与分期策略的临床结局。主要终点为5年全因死亡、心肌梗死和卒中的复合终点,单次组与分期组无显著差异(26.7% vs 23.0%,p=0.45;HR 0.91,95%CI 0.72-1.16,p=0.47)。单次组30天全因死亡发生率显著高于分期组(1.1% vs 0.2%,p=0.009),但死亡原因多与术前严重临床状态相关,而非操作并发症。
要点
- 单次与分期多支血管PCI的5年复合终点无显著差异。
- 单次组30天全因死亡发生率较高,但死亡多与术前状态相关。
- 亚组分析未显示单次策略效果存在显著异质性。
核心结论
- 单次多支血管PCI策略与分期策略相比,5年临床结局至少相当。
研究设计与样本
- 基于京都PCI/CABG注册队列-2的回顾性队列研究,纳入2018例择期多支血管PCI患者。
主要发现
- 单次组707例(35.0%),分期组1311例(65.0%)。
- 5年主要复合终点发生率单次组26.7%,分期组23.0%(p=0.45);调整后HR 0.91(95%CI 0.72-1.16,p=0.47)。
- 30天全因死亡发生率单次组1.1%,分期组0.2%(p=0.009)。
- 30天内11例死亡原因多与术前严重临床状态相关,非操作并发症。
- 亚组分析(年龄、性别、CAD范围、严重CKD、心衰)未显示显著交互作用。
临床怎么用
- 单次多支血管PCI可作为择期患者的可选策略,但需注意30天死亡风险。
- 术前应评估患者临床状态,严重临床情况可能影响单次策略的安全性。
局限性
- 单次策略在本研究中使用率较低(35.0%),可能影响结论外推。
- 为观察性注册研究,存在未测量混杂可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To clarify the effect of single-session multivessel percutaneous coronary intervention (PCI) strategy relative to the staged multivessel strategy on clinical outcomes in patients with stable coronary artery disease (CAD) or non-ST-elevation acute coronary syndrome. METHODS: In the Coronary REvascularisation Demonstrating Outcome Study in Kyoto PCI/coronary artery bypass grafting registry cohort-2, there were 2018 patients who underwent elective multivessel PCI. Primary outcome measure was composite of all-cause death, myocardial infarction and stroke at 5-year follow-up. RESULTS: Single-session multivessel PCI and staged multivessel PCI were performed in 707 patients (35.0%) and 1311 patients (65.0%), respectively. The cumulative 5-year incidence of and adjusted risk for the primary outcome measure were not significantly different between the single-session and staged groups (26.7% vs 23.0%, p=0.45; HR 0.91, 95% CI 0.72 to 1.16, p=0.47). The 30-day incidence of all-cause death was significantly higher in the single-session group than in the staged group (1.1% vs 0.2%, p=0.009). However, the causes of death in 11 patients who died within 30 days were generally not related to the procedural complications, but related to the serious clinical status before PCI. For the subgroup analyses including age, gender, extent of CAD, severe chronic kidney disease and heart failure, there was no significant interaction between the subgroup factors and the effect of the single-session strategy relative to the staged strategy for the primary outcome measure. CONCLUSIONS: The single-session multivessel PCI strategy was associated with at least comparable 5-year clinical outcomes compared with the staged multivessel PCI, although the prevalence of the single-session strategy was low in the present study.
引用
- Toyota T, Morimoto T, Shiomi H, et al. Single-session versus staged procedures for elective multivessel percutaneous coronary intervention. Heart. 2017. PMID: 29146627. doi:10.1136/heartjnl-2017-312117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。